Birdwatch Note Rating
2024-03-02 21:59:03 UTC - NOT_HELPFUL
Rated by Participant: 885B7C2A0675786A18A5653C373FA6FE86D17B02D3E9989AB02D1E73AFEA8100
Participant Details
Original Note:
There are fewer COVID treatments for immunocompromised patients in 2024 than 2022, and more barriers to access. Test & treatment costs have jumped (Paxlovid may be $1300 per course), and Paxlovid interferes with multiple meds high risk people may take. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-price-covid-19-drug-paxlovid-1400-five-day-course-wsj-2023-10-18/ https://www.npr.org/sections/goatsandsoda/2024/02/09/1230170175/coronavirus-faq-im-immunocompromised-will-pills-gargles-and-sprays-fend-off-covi
All Note Details